Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4.72x is 48% above its 3-year average of -9.05x, around the middle of its 3-year range (-265.61x–253.50x).
110.30% below its 12-month average of 45.84x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 253.50x.
INTEREST COVERAGE RATIO
-4.72x
INTEREST COVERAGE RATIO AVG TTM
45.84x
INTEREST COVERAGE RATIO AVG 3Y
-9.05x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-110.30%
CURRENT VS 3Y AVG
+47.84%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+18.48%
vs the sector median at left
Omada Health
Market Cap
$1.22B
Interest Coverage Ratio
-4.72x
TTM Avg
45.84x
3Y Avg
-9.05x
5Y Avg
N/A
Market Cap
$1.22B
Interest Coverage Ratio
N/A
TTM Avg
1.72x
3Y Avg
1.72x
5Y Avg
1.72x
Market Cap
$1.22B
Interest Coverage Ratio
15.57x
TTM Avg
15.57x
3Y Avg
15.57x
5Y Avg
10.02x
Market Cap
$1.22B
Interest Coverage Ratio
2.81x
TTM Avg
2.36x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$1.24B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.17B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
Interest Coverage Ratio
-4.99x
TTM Avg
16.08x
3Y Avg
16.08x
5Y Avg
16.08x
Market Cap
$1.15B
Interest Coverage Ratio
2.05x
TTM Avg
1.65x
3Y Avg
1.11x
5Y Avg
0.98x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omada Health (OMDA) | $1.22B | -4.72x | 45.84x | -9.05x | N/A |
| Cronos Group Inc. (CRON)vs › | $1.22B | N/A | 1.72x | 1.72x | 1.72x |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 15.57x | 15.57x | 15.57x | 10.02x |
| MannKind Corporation (MNKD)vs › | $1.22B | 2.81x | 2.36x | 1.69x | 1.69x |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -4.99x | 16.08x | 16.08x | 16.08x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 2.05x | 1.65x | 1.11x | 0.98x |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
Interest Coverage
-4.7x
Debt/Equity
0.00
Current Ratio
3.91
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 253.50x |
| 2026-03-31 | -265.61x |
| 2025-12-31 | 252.38x |
| 2025-09-30 | -7.12x |
| 2025-06-30 | -3.97x |
| 2025-03-31 | -7.82x |
| 2024-12-31 | -6.47x |
| 2024-09-30 | -7.43x |
| 2024-06-30 | -8.87x |
| 2024-03-31 | -15.92x |
| 2023-12-31 | -11.88x |
| 2023-09-30 | -11.97x |
